arrow
S

Srinidhi Varadharajan

st jude childrens research hospital
H指数:15
被引数:1,095

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma

ZFTA-RELA室管膜瘤中核输出作为治疗易损性

2026-05-030
OA
Dominant clones leverage developmental epigenomic states to drive ependymoma

优势克隆利用发育期表观基因组状态驱动室管膜瘤

Nature
IF48.5
2026-03-250
OAAI
Synthetic ZFTA-fusions pinpoint IDR acquisition as a mechanism of brain tumor development

合成ZFTA融合蛋白将IDR的获得确定为脑肿瘤发展的机制

2025-11-010
OAAI
DOMINANT MALIGNANT LINEAGE LEVERAGE RESTRICTED EPIGENOMIC PROGRAMS TO DRIVE EPENDYMOMA DEVELOPMENT

优势恶性谱系利用受限的表观基因组程序来驱动室管膜瘤发展

2025-11-010
OAAI
Nuclear Transport as a Therapeutic Vulnerability in ZFTA-RELA Ependymoma

ZFTA-RELA室管膜瘤中核转运作为治疗性易损靶点

2025-11-010
OAAI
Synthetic ZFTA fusions pinpoint disordered protein domain acquisition as a mechanism of brain tumorigenesis

合成ZFTA融合蛋白将无序蛋白质结构域的获取确定为脑肿瘤发生的一种机制

2025-08-270
OAAI
Histone serotonylation regulates ependymoma tumorigenesis

组蛋白血清素化调控室管膜瘤肿瘤发生

Nature
IF48.5
2024-07-310
PRE
ZFTA FUSION ONCOPROTEINS DRIVE ONCOGENESIS THROUGH ASSEMBLY OF BIOMOLECULAR CONDENSATES
2024-06-180
OAAI
An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma
2024-01-012
OA
H3K27M HISTONE MUTANT GLIOMAS ARE SENSITIVE TO METHIONINE LOSS AND MAT2A INHIBITION THROUGH A NOVEL FEEDBACK MECHANISM BETWEEN AMD1 AND METTL16
2023-06-120
OAAI
K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas
2022-12-0549
OA